These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 30597305)

  • 21. Regulation of spindle and kinetochore-associated protein 1 by antitumor miR-10a-5p in renal cell carcinoma.
    Arai T; Okato A; Kojima S; Idichi T; Koshizuka K; Kurozumi A; Kato M; Yamazaki K; Ishida Y; Naya Y; Ichikawa T; Seki N
    Cancer Sci; 2017 Oct; 108(10):2088-2101. PubMed ID: 28746769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor suppressor miR-33b-5p regulates cellular function and acts a prognostic biomarker in RCC.
    Huang G; Lai Y; Pan X; Zhou L; Quan J; Zhao L; Li Z; Lin C; Wang J; Li H; Yuan H; Yang Y; Lai Y; Ni L
    Am J Transl Res; 2020; 12(7):3346-3360. PubMed ID: 32774704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-212-5p inhibits the malignant behavior of clear cell renal cell carcinoma cells by targeting TBX15.
    Deng JH; Zheng GY; Li HZ; Ji ZG
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10699-10707. PubMed ID: 31858538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-129-3p, as a diagnostic and prognostic biomarker for renal cell carcinoma, attenuates cell migration and invasion via downregulating multiple metastasis-related genes.
    Chen X; Ruan A; Wang X; Han W; Wang R; Lou N; Ruan H; Qiu B; Yang H; Zhang X
    J Cancer Res Clin Oncol; 2014 Aug; 140(8):1295-304. PubMed ID: 24802708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-411 functions as a tumor suppressor in renal cell cancer.
    Zhang X; Zhang M; Cheng J; Lv Z; Wang F; Cai Z
    Int J Biol Markers; 2017 Oct; 32(4):e454-e460. PubMed ID: 28708205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-20b-5p functions as a tumor suppressor in renal cell carcinoma by regulating cellular proliferation, migration and apoptosis.
    Li Y; Chen D; Jin L; Liu J; Su Z; Li Y; Gui Y; Lai Y
    Mol Med Rep; 2016 Feb; 13(2):1895-901. PubMed ID: 26708577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-30b-5p functions as a tumor suppressor in cell proliferation, metastasis and epithelial-to-mesenchymal transition by targeting G-protein subunit α-13 in renal cell carcinoma.
    Liu W; Li H; Wang Y; Zhao X; Guo Y; Jin J; Chi R
    Gene; 2017 Aug; 626():275-281. PubMed ID: 28536082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulated microRNA-510-5p acts as a tumor suppressor in renal cell carcinoma.
    Chen D; Li Y; Yu Z; Li Y; Su Z; Ni L; Yang S; Gui Y; Lai Y
    Mol Med Rep; 2015 Aug; 12(2):3061-6. PubMed ID: 25936999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-532-5p suppresses renal cancer cell proliferation by disrupting the ETS1-mediated positive feedback loop with the KRAS-NAP1L1/P-ERK axis.
    Zhai W; Ma J; Zhu R; Xu C; Zhang J; Chen Y; Chen Z; Gong D; Zheng J; Chen C; Li S; Li B; Huang Y; Xue W; Zheng J
    Br J Cancer; 2018 Aug; 119(5):591-604. PubMed ID: 30082686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The miR-140-5p/KLF9/KCNQ1 axis promotes the progression of renal cell carcinoma.
    Huang C; Li J; Zhang X; Xiong T; Ye J; Yu J; Gui Y
    FASEB J; 2020 Aug; 34(8):10623-10639. PubMed ID: 32596959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncogenic miR-663a is associated with cellular function and poor prognosis in renal cell carcinoma.
    Zhou L; Pan X; Li Z; Chen P; Quan J; Lin C; Lai Y; Xu J; Xu W; Guan X; Li H; Gui Y; Lai Y
    Biomed Pharmacother; 2018 Sep; 105():1155-1163. PubMed ID: 30021352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations of high expression of miR-106b-5p detected from FFPE sample with poor prognosis of RCC patients.
    Liu K; Pan X; Peng X; Zhang C; Li H; Guan X; Xu W; Xu J; Zhao L; Wang T; Lai Y
    Pathol Res Pract; 2019 Jun; 215(6):152391. PubMed ID: 31076282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased miR-200a-3p is a key regulator of renal carcinoma growth and migration by directly targeting CBL.
    Ding M; Sun X; Zhong J; Zhang C; Tian Y; Ge J; Zhang CY; Zen K; Wang JJ; Zhang C; Wang C
    J Cell Biochem; 2018 Dec; 119(12):9974-9985. PubMed ID: 30171729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The long noncoding RNA EMBP1 inhibits the tumor suppressor miR-9-5p and promotes renal cell carcinoma tumorigenesis.
    Hong Y; Yuan Z; Huang R; Wu Z; Li Y
    Nefrologia (Engl Ed); 2020; 40(4):429-439. PubMed ID: 32482375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
    Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
    Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long non-coding RNA CYTOR modulates cancer progression through miR-136-5p/MAT2B axis in renal cell carcinoma.
    Wang D; Zhu X; Siqin B; Ren C; Yi F
    Toxicol Appl Pharmacol; 2022 Jul; 447():116067. PubMed ID: 35597301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of miR-486-5p in regulating renal cell carcinoma cell proliferation and apoptosis via TGF-β-activated kinase 1.
    He Y; Liu J; Wang Y; Zhu X; Fan Z; Li C; Yin H; Liu Y
    J Cell Biochem; 2019 Mar; 120(3):2954-2963. PubMed ID: 30537206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma (HCC) via suppressing MAD2L1.
    Li Y; Bai W; Zhang J
    Biomed Pharmacother; 2017 Aug; 92():1038-1044. PubMed ID: 28609841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-183-5p promotes renal cell carcinoma metastasis by targeting TET1.
    Jin S; Chen L; Wu J; Chen M; Wang H; Hu H; Yu L; Zeng S
    Int J Immunopathol Pharmacol; 2023; 37():3946320231184997. PubMed ID: 37584255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma.
    Lu R; Ji Z; Li X; Zhai Q; Zhao C; Jiang Z; Zhang S; Nie L; Yu Z
    J Cancer Res Clin Oncol; 2014 Mar; 140(3):387-97. PubMed ID: 24384875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.